These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25882637)

  • 21. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ethanol on the anticancer function of doxorubicin in JJ012 cells.
    Huang H; Li Y; Wu M; Luo J; Nie J; Hou B; He Q; Diao Y; Qi L; Zhao Y; Liu Y; Yang D; Zhou L
    Future Oncol; 2018 Jun; 14(13):1285-1297. PubMed ID: 29774752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.
    Bajo AM; Schally AV; Halmos G; Nagy A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3742-8. PubMed ID: 14506166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance.
    Skildum A; Dornfeld K; Wallace K
    Breast Cancer Res Treat; 2011 Oct; 129(3):785-97. PubMed ID: 21128112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
    Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA
    Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.
    Raposo LR; Roma-Rodrigues C; Jesus J; Martins LMDRS; Pombeiro AJ; Baptista PV; Fernandes AR
    Vet Comp Oncol; 2017 Dec; 15(4):1537-1542. PubMed ID: 28150469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
    Wang JC; Liu XY; Lü WL; Lee HS; Goh BC; Zhang Q
    Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Overexpression of heat shock protein 27 reduces mortality and attenuates cardiac dysfunction induced by doxorubicin in a transgenic mouse model].
    Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):595-8. PubMed ID: 17961420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
    Torres CG; Olivares A; Stoore C
    Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
    Serrano C; Guzmán S; Arias JI; Torres CG
    BMC Vet Res; 2019 Nov; 15(1):390. PubMed ID: 31684950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line.
    Pawłowski KM; Popielarz D; Szyszko K; Gajewska M; Motyl T; Król M
    Vet Comp Oncol; 2012 Mar; 10(1):2-15. PubMed ID: 22235976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs.
    Díaz Bessone MI; Berardi DE; Campodónico PB; Todaro LB; Lothstein L; Bal de Kier Joffé ED; Urtreger AJ
    Breast Cancer Res Treat; 2011 Apr; 126(3):577-87. PubMed ID: 20512658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
    Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
    Pavan S; Musiani D; Torchiaro E; Migliardi G; Gai M; Di Cunto F; Erriquez J; Olivero M; Di Renzo MF
    Int J Cancer; 2014 Mar; 134(6):1289-99. PubMed ID: 23996744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldoxorubicin-loaded nanofibers are cytotoxic for canine mammary carcinoma and osteosarcoma cell lines in vitro: A short communication.
    Stokol T; Wan C; Blakely R; Bellat V; Law B
    Res Vet Sci; 2020 Feb; 128():86-89. PubMed ID: 31760317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers.
    Matsunaga T; Kezuka C; Morikawa Y; Suzuki A; Endo S; Iguchi K; Miura T; Nishinaka T; Terada T; El-Kabbani O; Hara A; Ikari A
    Biol Pharm Bull; 2015; 38(9):1309-19. PubMed ID: 26328486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.